P. Velou

Remdesivir for the treatment of hospitalised patients with COVID-19: final results from the DisCoVeRy randomised, controlled, open-label trial

R. Greil, Y. Yazdanpanah, F. Raffi, 2022, medRxiv.

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

R. Greil, Y. Yazdanpanah, C. Marquette, 2021, The Lancet Infectious Diseases.

Remdesivir for the Treatment of Hospitalised Patients with COVID-19 (DisCoVeRy): A Randomised, Controlled, Open-Label Trial

R. Greil, Y. Yazdanpanah, D. Costagliola, 2021, SSRN Electronic Journal.